8 research outputs found

    Hepatic tumor diagnosis by analysing dense transport fields in contrast-enhanced ultrasound

    Get PDF
    International audienceDynamic contrast agent enhanced ultrasound (DCEUS) is considered as a safe, noninvasive, accurate, and economic tool for analysing blood perfusion of various organs [1]. Gas-filled mi-crobubble contrast agents are used as intravascular flow tracers. In this study, a new methodology is proposed to quantify the divergence (i.e sources, sinks), curl (i.e sheering) and amplitude in the apparent microbubble transports during the bolus arrival. The efficiency of proposed methodology is evaluated in-vivo, for the classification of focal nodular hyperplasia (FNH) and inflammatory hepatic adenomas (I-HCA)

    Hepatic tumor diagnosis by analysing dense transport fields in contrast-enhanced ultrasound

    Get PDF
    International audienceDynamic contrast agent enhanced ultrasound (DCEUS) is considered as a safe, noninvasive, accurate, and economic tool for analysing blood perfusion of various organs [1]. Gas-filled mi-crobubble contrast agents are used as intravascular flow tracers. In this study, a new methodology is proposed to quantify the divergence (i.e sources, sinks), curl (i.e sheering) and amplitude in the apparent microbubble transports during the bolus arrival. The efficiency of proposed methodology is evaluated in-vivo, for the classification of focal nodular hyperplasia (FNH) and inflammatory hepatic adenomas (I-HCA)

    Hepatic tumor diagnosis by analysing dense transport fields in contrast-enhanced ultrasound

    No full text
    Dynamic contrast agent enhanced ultrasound (DCEUS) is considered as a safe, noninvasive, accurate, and economic tool for analysing blood perfusion of various organs [1]. Gas-filled mi-crobubble contrast agents are used as intravascular flow tracers. In this study, a new methodology is proposed to quantify the divergence (i.e sources, sinks), curl (i.e sheering) and amplitude in the apparent microbubble transports during the bolus arrival. The efficiency of proposed methodology is evaluated in-vivo, for the classification of focal nodular hyperplasia (FNH) and inflammatory hepatic adenomas (I-HCA)
    corecore